Motivation and Knowledge of Portuguese Community Pharmacists Towards the Reporting of Suspected Adverse Reactions to Medicines: A Cross-Sectional Survey

被引:2
|
作者
Ferreira-da-Silva, Renato [1 ,2 ,3 ]
Alves, Joao Miguel [2 ,3 ]
Vieira, Carina [4 ]
Silva, Ana Marta [1 ,2 ,3 ]
Marques, Joana [1 ,2 ,3 ]
Morato, Manuela [5 ]
Polonia, Jorge Junqueira [1 ,3 ,6 ]
Ribeiro-Vaz, Ines [1 ,2 ,3 ]
机构
[1] Univ Porto, Porto Pharmacovigilance Ctr, Fac Med, Rua Doutor Placid da Costa, P-4200450 Porto, Portugal
[2] Univ Porto, Fac Med, Dept Community Med Hlth Informat & Decis, Porto, Portugal
[3] CINTESIS Ctr Hlth Technol & Serv Res, Porto, Portugal
[4] Univ Porto, Fac Pharm, Dept Chem Sci, LAQV REQUIMTE, Porto, Portugal
[5] Univ Porto, Fac Pharm, Dept Drug Sci, Lab Pharmacol,LAQV REQUIMTE, Porto, Portugal
[6] Univ Porto, Fac Med, Dept Med, Porto, Portugal
关键词
Adverse drug reaction reporting systems; Health knowledge; Attitudes; Practice; Pharmacist; Community Pharmacist; Pharmacovigilance; Drug monitoring; HEALTH-CARE PROFESSIONALS; DRUG-REACTIONS; HOSPITAL PHARMACISTS; PHYSICIANS ATTITUDES; MOBILE APP; PHARMACOVIGILANCE; SAFETY;
D O I
10.1007/s10900-022-01168-3
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The close contact between patients and community pharmacists, along with the extensive geographical distribution of pharmacies in Portugal, offer exceptional conditions to detect and report adverse drug reactions (ADR). This study aimed to evaluate the motivation and knowledge of spontaneous reporting of ADR by community pharmacists of Porto, Portugal. Secondly, we aimed to generate real-world evidence on the main factors determining ADR report and at raising potential alternatives to the current reporting procedure in community pharmacy. We performed a descriptive, cross-sectional, observational, anonymous web survey-based study. Between April and July 2021, a web survey was implemented, targeting community pharmacists in the Porto district, Portugal. We validated 217 surveys from pharmacists. Regular notifiers seem to be more familiarised than non-regular notifiers with the Portuguese Pharmacovigilance System (PPS), with the Portal RAM for reporting suspected ADR, and with the update of the concept of ADR. Moreover, regular notifiers seem to be more proactive with their care in questioning patients about ADR and have more self-knowledge to identify suspected ADR. Conversely, non-regular notifiers, seem to be more reluctant to be judged by their ADR reporting activities. Respondents suggested to simplify and optimise the reporting process (31% of the suggestions), or to integrate a reporting platform into the pharmacy's software (27%). This study identified opportunities to promote the ADR reporting process by community pharmacists, namely receiving feedback from the PPS on the reported case and its regulatory implications, implementing training programs in pharmacovigilance, and creating solutions to simplify the reporting process.
引用
收藏
页码:295 / 308
页数:14
相关论文
共 50 条
  • [41] Alabama community pharmacists' knowledge and perceptions regarding fentanyl test strips: A cross-sectional survey
    Woods, Shannon
    Blythe, Erin
    Valle-Ramos, Giovanna
    Richardson, Jessica
    Pham, Karen
    Diggs, Kavon
    Harris, Klaudia
    Zhao, Yi
    Hohmann, Lindsey
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2025, 65 (01)
  • [42] Reporting, handling, and subjective importance of adverse drug reactions among general practitioners: an exploratory cross-sectional survey
    Gahr, Maximilian
    Connemann, Bernhard
    Zeiss, Rene
    Schoenfeldt-Lecuona, Carlos
    Dreyhaupt, Jens
    Lazik, Christopher
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (08) : 979 - 985
  • [43] A Survey of Pharmacists and Other Healthcare Professionals in Vietnam: Factors Influencing Knowledge and Attitudes Toward Reporting Adverse Drug Reactions
    Tran, Van De
    Tran, Thi Ngoc Kieu
    Vo, Quang Loc Duyen
    Pham, Kieu Anh Tho
    Dewey, Rebecca Susan
    Van, Cong Khanh
    Dorofeeva, Valeria Valeryevna
    HOSPITAL PHARMACY, 2024, 59 (01) : 56 - 69
  • [44] Herbal supplements in Jordan: a cross-sectional survey of pharmacists' perspectives and knowledge
    Jalil, Banaz
    Naser, Abdallah Y.
    Prieto, Jose M.
    Heinrich, Michael
    BMJ OPEN, 2022, 12 (07):
  • [45] Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study
    Hussain, Saad Abdulrahman
    Abbas, Ashwaq Nagemeldeen
    Habeeb, Shah-Zanan Alaa
    Abd-Ali, Athraa Kareem
    Abdulrahman, Zainab Saad
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (05) : 1307 - 1313
  • [46] Evaluation of the knowledge, practices, and attitudes of community pharmacists towards adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs): a cross-sectional study
    Barakat, Hadeer Ehab
    Aziz, Christine Nazir
    Abougalambou, Salwa Selim Ibrahim
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)
  • [47] Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey
    Hussain, Rabia
    Hassali, Mohamed Azmi
    Hashmi, Furqan
    Akram, Tayyaba
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2021, 14 (01)
  • [48] Exploring healthcare professionals’ knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey
    Rabia Hussain
    Mohamed Azmi Hassali
    Furqan Hashmi
    Tayyaba Akram
    Journal of Pharmaceutical Policy and Practice, 14
  • [49] Knowledge, attitude and perception of community pharmacists towards pharmacogenomics services in northern Nigeria: a cross-sectional study
    Abubakar, Usman
    Subramaniam, Lienarrubini
    Ayinla, Abdulkadir
    Ambali, Mobolaji Nurudeen
    Noor, Dzul Azri Mohamed
    Daud, Nur Aizati Athirah
    Isah, Hauwa Kulu
    Al-Shami, Hiba A.
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2022, 15 (01)
  • [50] Assessment of Knowledge and Attitudes of Physicians and Pharmacists on Probiotics: A Cross-Sectional Survey
    Basar Gunes, Hulya
    Bayraktar Ekincioglu, Aygin
    Karakan, Tarkan
    Demirkan, Kutay
    TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 21 (01) : 36 - 41